| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Mo Qatanani | CHIEF SCIENTIFIC OFFICER | 2026-02-23 | 200 | $48.48 | $9.70kSell |
| Mo Qatanani | CHIEF SCIENTIFIC OFFICER | 2026-02-23 | 7,427 | $46.94 | $348.64kSell |
| Mo Qatanani | CHIEF SCIENTIFIC OFFICER | 2026-02-23 | 857 | $47.86 | $41.02kSell |
| Junlin Ho | GENERAL COUNSEL | 2026-02-17 | 9,580 | $46.53 | $445.74kSell |
| Caryn Parlavecchio | CHRO | 2026-02-17 | 9,035 | $46.53 | $420.38kSell |
| Mo Qatanani | CHIEF SCIENTIFIC OFFICER | 2026-02-17 | 7,989 | $46.53 | $371.71kSell |
| Jing L. Marantz | CHIEF MEDICAL OFFICER | 2026-02-17 | 4,157 | $46.53 | $193.42kSell |
| Mo Qatanani | CHIEF SCIENTIFIC OFFICER | 2026-01-22 | 12,779 | $46.85 | $598.75kSell |
| Mo Qatanani | CHIEF SCIENTIFIC OFFICER | 2026-01-22 | 2,119 | $45.87 | $97.19kSell |
| Mo Qatanani | CHIEF SCIENTIFIC OFFICER | 2026-01-16 | 8,406 | $44.48 | $373.88kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Srinivas Akkaraju | 14.64% | 16,820,422 | $826.89M | Insider |
| Fmr LLC | 13.39% | 15,380,675 | $756.11M | Institution |
| Siren LLC | 9.80% | 11,259,438 | $553.51M | Insider |
| Invus Global Management LLC | 9.42% | 10,825,013 | $532.16M | Insider |
| Siren LLC | 9.42% | 10,825,013 | $532.16M | Institution |
| Invus Public Equities LP | 8.05% | 9,250,005 | $454.73M | Insider |
| Blackrock Inc | 6.28% | 7,217,034 | $354.79M | Institution |
| Samsara Biocapital LLC | 6.00% | 6,897,652 | $339.09M | Institution |
| Samsara Biocapital GP LLC | 5.91% | 6,788,609 | $333.73M | Insider |
| Price T Rowe Associates Inc | 5.57% | 6,402,437 | $314.74M | Institution |